Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00295503
Status:
COMPLETED
Last Update Posted:
2020-10-20
First Post:
2006-02-22
Brief Title:
Cisplatin Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Organization Data
Organization:
University of Texas Southwestern Medical Center
Class:
OTHER
Study ID:
AVF3442S
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Texas Southwestern Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Duke University | OTHER |
| University of Chicago | OTHER |
| Columbia University | OTHER |